Oncology

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.

A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.

A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.

A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.